Executive Board

Prof. Maciej Żylicz
President of the Board
They also presented inceptive and introductory mechanistic evidence that heat shock proteins act as molecular chaperones by protecting other proteins from aggregation and dissociate already existing protein aggregates. Moreover, Maciej?s group was one of the first to describe that elements of the proteolytic machinery possess chaperone activity. Recently, Maciej?s and Alicja?s laboratory discovered that molecular chaperones are required for the transcriptional activity of wild-type p53 tumour suppressor protein and that it's chief negative regulator the MDM2 oncoprotein possesses intrinsic chaperone-like activity. Moreover, they were among the first to present evidence that heat shock proteins are also directly involved in gaining new oncogenic functions of mutated p53 tumour suppressor, leading to tumour development, metastasis and acquisition of chemoresistance of breast cancer patients. Recently, they showed that the expression profile of heat shock genes creates a prognostic signature which can be used to predict the clinical outcome of breast cancer. Professor Zylicz is a full member of the Polish Academy of Sciences, member of the German National Academy of Sciences - Leopoldina, Academia Europae and the European Cancer Research Academy, and corresponding member of the Polish Academy of Arts and Sciences. He is also a member of the European Molecular Biology Organization (EMBO), and was a member of its Council in 2003-2007. In 2008-2010 he chaired the Molecular and Structural Biology and Biochemistry Panel (LS1) of the European Research Council. He also served as the Polish delegate to the European Molecular Biology Conference (2000-2004) and the European Science Foundation (2003-2005). He was a member of the ERC Identification Committee (2010-2013). He was awarded the title of honorary doctorate from several Universities: University of Wroclaw (2007), University of Gdansk (2011) and Jagiellonian University (2013). He acted as science advisor to the President of the Republic of Poland (2010-2015). Since 2012 he has been a member of Max Planck Senate and since 2020 a member of the Trustee Committee of the Körber European Science Prize.
- Article: Święty Graal innowacyjności, ['Saint Graal of innovation'] "Rzeczpospolita", 11th November 2013
- Article 'Potrzebujemy dalszych zmNauka3_2012_02-Zyliczian' ['We need more changes'], Nauka 3/2012
- Article: On higher education reform ? Contribution to debate, Forum Akademickie, issue 1/2011
- Article: 'Polish Science Reforms Bring Fear and Hope', Science weekly, 19th March 2010
- Article: 'Z czwartej setki' ['In the 300s'] (Summary of 20 years of reform of Polish sciences and education), Forum Akademickie, issue 7-8/2009
- Speech: Investments in science are investments in the future, Poland Club 2015+, 26th November 2008
- Article: 'Reforma sektora nauki' ['Reform of the science sector'] (co-author)
- Article: 'On higher education reform' for the Sprawy Nauki ['Science Matters'] annual

PhD Marta Łazarowicz-Kowalik
Deputy President of the Board
Among other places, she worked at the PZU Foundation (2004–2007), the Ashoka: Innovators for the Public (2000–2002), and the Academy for the Development of Philanthropy in Poland (2000–2003). Between 2003 and 2004, she served as Secretary of the III Sektor (3rd Sector) editorial board, a quarterly dedicated to building scientific background for NGOs and presenting knowledge on the development of civil society in Poland and around the world. Before joining the NGO community, she worked as a journalist in the economic press: Życie Gospodarcze, Gazeta Bankowa, Businessman Magazine. She has been appointed Deputy President of the FNP Board as of October 1, 2023.

PhD Tomasz Perkowski
Deputy President of the Board
In January 1999 he was appointed director of the Social Communication Department of the West Pomeranian Regional Health Fund. From March to December 2000 he was employed at the Szczecin Municipal Board Press Office. He was a member of the National Environmental Protection Fund?s Supervisory Board in 2001. He joined the Foundation for Polish Science in December 2000 as its director for development. Following a decision of the Foundation Council, he was appointed vice-president of the Foundation Board on 1 December 2001.

Prof. Krzysztof Pyrć
Expert/Board Advisor, President-elect of the Board
The scope of research is constantly being expanded and modified, in response to emerging threats and technological developments. Prof. Pyrć’s team specializes in viruses that pose a threat in the twenty-first century, i.e., coronaviruses, flaviviruses, alphaviruses, and influenza viruses. To better understand the processes in the human body, Prof. Pyrć and his team created a unique research workshop based on three-dimensional tissue cultures and the lab is currently working on reproducing the complex ecosystem of the human body. Thanks to the results of research by Prof. Pyrć, it has been possible to learn the course of the infection process for many human and animal viruses, which has led to the creation of new substances with therapeutic effects.
Prof. Pyrć is the author of over 140 publications in, among others, Nature Medicine, Science Translational Medicine, PNAS, PloS Pathogens, Journal of Virology, and Science Signalling, which scholars have been cited over 7000 times in the world literature (h=41; WoS). Moreover, he is a reviewer and expert at science funding institutions in Poland and abroad (Horizon2020, ERC, FNP, NCN, and others). He holds advisory positions at the level of the European Commission and the Ministry of Health. He has been involved in advisory bodies of local governments, the Ministry of Science, the Prime Minister, and the President of Poland.
He managed numerous research grants, including those under Horizon2020, IMI2, European Cooperation in Science and Technology, the National Science Center, the Foundation for Polish Science, the National Center for Research and Development, and the Ministry of Science and Higher Education, as well as those funded by commercial entities. From 2009 to 2016, he was the Scientific Coordinator of the Molecular Biotechnology for Health program at Jagiellonian University. Since 2017, he has been a member of the Council of the Malopolska Centre of Biotechnology. In 2020, he was appointed to the advisory team of the Minister of Science and Higher Education ‘for activities related to the prevention, counteraction and eradication of COVID-19.’ He is deputy chairman of the advisory team on COVID-19 to the President of the Polish Academy of Sciences and a member of the program board of the Science Against Pandemic initiative. Member of the Medical Council to the Prime Minister. Expert of the Agency for Health Technology Assessment and Tariff System on the diagnosis of SARS-CoV-2 therapy. He is currently a member of the presidium of a committee of the Polish Academy of Sciences (infectious diseases, health problems associated with climate change). He is a member of the American Society for Virology (ASV), European Society for Virology (EuSV), Association of POLITYKA Scholars, Polish Society of Virology, and Polish Society of Cell Biology. Laureate of Foundation programs: START (2008) and POWROTY/HOMING (2008). Winner of numerous awards and honors, including: the POLITYKA weekly scholarship (2008), the European Society for Virology Award (2010), the Prize of the Minister of Science (2020), the title of the Man of the Year of Gazeta Krakowska (2021), the Nicolaus Copernicus Award of the Polish Academy of Sciences (2021), the City of Krakow Award (2021), the Saint Christopher Medal awarded by the Museum of the City of Krakow (2023), the Prize for Outstanding Achievements in Invention awarded by CITTRU (2023). He has topped the list of the most influential people in Polish medicine of Pulse of Medicine since 2021.
Prof. Pyrć was appointed to the position of President of the FNP’s Executive Board by the Foundation’s Council, effective September 1, 2025.